Why did FDA withdraw tanning bed minors rule?

FDA withdraws proposed tanning-bed age ban

The FDA has withdrawn a proposed rule that would have barred Americans under age 18 from using tanning beds. The initiative was first brought forward more than a decade ago, but the agency ultimately decided not to move forward with it.

This matters because tanning beds are widely associated with increased ultraviolet (UV) exposure—an established risk factor for skin cancer. A federal rule would have standardized restrictions across states and potentially reduced access for teens and other minors who may be especially likely to develop long-term effects from repeated UV exposure.

The withdrawal means the federal approach is no longer on track, leaving in place whatever existing state laws, industry practices, and public health guidance remain in effect. Without a uniform rule, the degree of protection for minors can vary depending on local regulations and how tanning facilities choose to age-restrict customers.

For consumers and parents, the immediate practical takeaway is that the proposed federal ban is off the table for now, so risk-reduction efforts remain focused on avoiding tanning beds altogether and relying on sunscreen and other sun-safety measures. Medical groups have continued to warn about harms from indoor tanning even as policymakers adjust the regulatory landscape.

If new regulations emerge, they could take a different form than the withdrawn age-based ban. For now, the FDA’s decision shifts the conversation back toward existing safeguards and public education rather than a single nationwide restriction.